title: Inhibitors of the influenza A virus M2 proton channel discovered using a high-throughput yeast growth restoration assay.
abstract: The M2 proton channel of the influenza A virus is the target of the anti-influenza drugs amantadine and rimantadine. The effectiveness of these drugs has been dramatically limited by the rapid spread of drug resistant mutations, mainly at sites S31N, V27A and L26F in the pore of the channel. Despite progress in designing inhibitors of V27A and L26F M2, there are currently no drugs targeting these mutated channels in clinical trials. Progress in developing new drugs has been hampered by the lack of a robust assay with sufficient throughput for discovery of new active chemotypes among chemical libraries and sufficient sensitivity to provide the SAR data essential for their improvement and development as drugs. In this study we adapted a yeast growth restoration assay, in which expression of the M2 channel inhibits yeast growth and exposure to an M2 channel inhibitor restores growth, into a robust and sensitive high-throughput screen for M2 channel inhibitors. A screen of over 250,000 pure chemicals and semi-purified fractions from natural extracts identified 21 active compounds comprising amantadine, rimantadine, 13 related adamantanes and 6 non-adamantanes. Of the non-adamantanes, hexamethylene amiloride and a triazine derivative represented new M2 inhibitory chemotypes that also showed antiviral activity in a plaque reduction assay. Of particular interest is the fact that the triazine derivative was not sufficiently potent for detection as an inhibitor in the traditional two electrode voltage clamp assay for M2 channel activity, but its discovery in the yeast assay led to testing of analogues of which one was as potent as amantadine.
authors: Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, British Columbia, Canada.
authors: Aruna D
authors: AD
authors: Balgi
authors: Jun
authors: J
authors: Wang
authors: Daphne Y H
authors: DY
authors: Cheng
authors: Chunlong
authors: C
authors: Ma
authors: Tom A
authors: TA
authors: Pfeifer
authors: Yoko
authors: Y
authors: Shimizu
authors: Hilary J
authors: HJ
authors: Anderson
authors: Lawrence H
authors: LH
authors: Pinto
authors: Robert A
authors: RA
authors: Lamb
authors: William F
authors: WF
authors: DeGrado
authors: Michel
authors: M
authors: Roberge
mesh_terms: D000998:Antiviral Agents / Q000302:isolation & purification* / Q000494:pharmacology; D055808:Drug Discovery / Q000379:methods*; D057166:High-Throughput Screening Assays / Q000379:methods*; D020125:Mutation, Missense / Q000235:genetics; D018408:Patch-Clamp Techniques; D012680:Sensitivity and Specificity; D014763:Viral Matrix Proteins / Q000037:antagonists & inhibitors* / Q000235:genetics*; D015003:Yeasts / Q000187:drug effects / Q000254:growth & development; D000086082:Viroporin Proteins
chemical_list: D000998:Antiviral Agents; D014763:Viral Matrix Proteins; C488937:M2 protein, Influenza A virus; D000086082:Viroporin Proteins
references: Cell. 1991 Oct 4;67(1):117-30
references: 1913813
references: Science. 2010 Oct 22;330(6003):505-8
references: 20966251
references: ACS Med Chem Lett. 2011 Apr 14;2(4):307-312
references: 21691418
references: J Nat Prod. 2008 Mar;71(3):464-8
references: 18257534
references: Virology. 1992 Dec;191(2):541-9
references: 1448912
references: Virol J. 2009 May 29;6:67
references: 19476650
references: Antimicrob Agents Chemother. 2010 May;54(5):2017-22
references: 20194696
references: Nat Chem Biol. 2007 Aug;3(8):466-79
references: 17637779
references: J Am Chem Soc. 2009 Jun 17;131(23):8066-76
references: 19469531
references: Nature. 2008 Jan 31;451(7178):591-5
references: 18235503
references: J Membr Biol. 1988 Oct;105(1):1-21
references: 2852254
references: Virology. 1992 Sep;190(1):11-8
references: 1529523
references: Lancet Infect Dis. 2012 Sep;12(9):651-3
references: 22738892
references: J Biol Chem. 2001 May 25;276(21):17914-9
references: 11279124
references: Biotechnol J. 2006 Mar;1(3):282-8
references: 16897708
references: J Nat Prod. 2012 Jan 27;75(1):72-81
references: 22204643
references: JAMA. 2006 Feb 22;295(8):891-4
references: 16456087
references: J Infect Dis. 2011 Jan 1;203(1):18-24
references: 21148492
references: Science. 2010 Oct 22;330(6003):456-8
references: 20966238
references: Biochim Biophys Acta. 2011 Jan;1808(1):394-8
references: 20831860
references: J Cell Biol. 1996 May;133(4):733-47
references: 8666660
references: Pflugers Arch. 2010 Mar;459(4):593-605
references: 19946785
references: Curr Opin Struct Biol. 2011 Feb;21(1):68-80
references: 21247754
references: Antimicrob Agents Chemother. 2009 Oct;53(10):4457-63
references: 19651904
references: J Med Chem. 2012 Jul 26;55(14):6263-77
references: 22612288
references: Science. 2010 Oct 22;330(6003):509-12
references: 20966252
references: Lancet. 2005 Oct 1;366(9492):1175-81
references: 16198766
references: Eur Biophys J. 2002 Mar;31(1):26-35
references: 12046895
references: Proc Natl Acad Sci U S A. 2010 Aug 31;107(35):15409-14
references: 20713739
references: J Am Chem Soc. 2011 Mar 30;133(12):4274-84
references: 21381693
references: FEBS Lett. 1995 Jan 9;357(3):269-74
references: 7530665
references: Antimicrob Agents Chemother. 1995 Oct;39(10):2204-9
references: 8619568
references: PLoS Biol. 2006 Feb;4(2):e50
references: 16464130
references: Proc Natl Acad Sci U S A. 2010 Aug 24;107(34):15075-80
references: 20689043
references: J Med Chem. 2010 May 13;53(9):3831-4
references: 20394375
references: J Infect Dis. 2011 Jan 1;203(1):13-7
references: 21148491
references: Nat Chem Biol. 2009 Nov;5(11):849-56
references: 19783991
references: Mol Pharmacol. 1986 Aug;30(2):112-20
references: 3016497
references: Eur J Med Chem. 2011 Jan;46(1):52-7
references: 21094565
references: Nature. 2008 Jan 31;451(7178):596-9
references: 18235504
references: Nature. 2010 Feb 4;463(7281):689-92
references: 20130653
references: Cell. 1992 May 15;69(4):577-8
references: 1375129
references: Curr Top Microbiol Immunol. 2013;370:273-300
references: 22246228
references: PLoS Pathog. 2009 Jul;5(7):e1000511
references: 19593379
references: J Gen Virol. 1997 Apr;78 ( Pt 4):767-74
references: 9129648
references: Methods Mol Biol. 2009;486:125-37
references: 19347620
references: FEBS Lett. 2004 Jan 16;557(1-3):99-103
references: 14741348
references: J Med Chem. 1995 Oct 27;38(22):4474-7
references: 7473574
references: J Am Chem Soc. 2011 Aug 17;133(32):12834-41
references: 21744829
references: Biochemistry. 2009 Dec 22;48(50):11872-82
references: 19905033
references: J Infect Dis. 2011 Jan 1;203(1):6-10
references: 21148489
references: Bioorg Med Chem Lett. 2010 Jul 15;20(14):4182-7
references: 20570509